Bank of America’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.7M Buy
866,061
+65,884
+8% +$1.22M ﹤0.01% 2449
2025
Q4
$11M Sell
800,177
-4,783
-0.6% -$74.5K ﹤0.01% 2781
2025
Q3
$14.2M Buy
804,960
+21,424
+3% +$339K ﹤0.01% 2940
2025
Q2
$11.8M Buy
783,536
+5,775
+0.7% +$95.8K ﹤0.01% 3084
2025
Q1
$12.5M Sell
777,761
-10,693
-1% -$199K ﹤0.01% 2913
2024
Q4
$13.7M Buy
788,454
+2,884
+0.4% +$50.8K ﹤0.01% 2627
2024
Q3
$13.8M Buy
785,570
+2,986
+0.4% +$50.9K ﹤0.01% 2760
2024
Q2
$8.76M Buy
782,584
+3,032
+0.4% +$28.6K ﹤0.01% 3067
2024
Q1
$6.79M Sell
779,552
-21,789
-3% -$200K ﹤0.01% 3344
2023
Q4
$9.81M Buy
801,341
+9,371
+1% +$64.9K ﹤0.01% 2916
2023
Q3
$3.19M Buy
791,970
+9,463
+1% +$58.8K ﹤0.01% 3819
2023
Q2
$5.63M Buy
782,507
+9,773
+1% +$62.4K ﹤0.01% 3287
2023
Q1
$2.6M Buy
772,734
+3,994
+0.5% +$12K ﹤0.01% 4114
2022
Q4
$2.13M Sell
768,740
-558
-0.1% -$1.25K ﹤0.01% 4200
2022
Q3
$1.77M Buy
769,298
+195
+0% +$317 ﹤0.01% 4389
2022
Q2
$1.18M Sell
769,103
-51,287
-6% -$129K ﹤0.01% 4775
2022
Q1
$3.99M Buy
820,390
+39,645
+5% +$324K ﹤0.01% 3872
2021
Q4
$11.6M Buy
780,745
+5,788
+0.7% +$115K ﹤0.01% 2772
2021
Q3
$16.7M Buy
774,957
+758,622
+4,644% +$16.3M ﹤0.01% 2329
2021
Q2
$268K Sell
16,335
-18,565
-53% -$353K ﹤0.01% 5875
2021
Q1
$826K Buy
34,900
+15,890
+84% +$475K ﹤0.01% 5006
2020
Q4
$453K Sell
19,010
-1,292
-6% -$20.6K ﹤0.01% 5078
2020
Q3
$239K Buy
20,302
+226
+1% +$2.43K ﹤0.01% 5188
2020
Q2
$210K Buy
20,076
+2,598
+15% +$23.4K ﹤0.01% 5212
2020
Q1
$126K Sell
17,478
-1,228
-7% -$12.7K ﹤0.01% 5392
2019
Q4
$250K Sell
18,706
-865
-4% -$12.3K ﹤0.01% 5482
2019
Q3
$302K Buy
19,571
+544
+3% +$7.07K ﹤0.01% 5411
2019
Q2
$251K Buy
19,027
+2,714
+17% +$37K ﹤0.01% 5507
2019
Q1
$287K Sell
16,313
-4,406
-21% -$69.1K ﹤0.01% 5339
2018
Q4
$237K Sell
20,719
-2,363
-10% -$28.6K ﹤0.01% 5414
2018
Q3
$328K Buy
23,082
+6,981
+43% +$99.2K ﹤0.01% 5217
2018
Q2
$244K Buy
16,101
+13,899
+631% +$235K ﹤0.01% 5298
2018
Q1
$29K Buy
2,202
+1,020
+86% +$19.4K ﹤0.01% 6252
2017
Q4
$28K Buy
1,182
+655
+124% +$15.5K ﹤0.01% 6304
2017
Q3
$10K Buy
527
+413
+362% +$9.38K ﹤0.01% 6547
2017
Q2
$3K Sell
114
-1,211
-91% -$33.3K ﹤0.01% 6679
2017
Q1
$27K Buy
1,325
+75
+6% +$1.02K ﹤0.01% 6194
2016
Q4
$8K Sell
1,250
-2,500
-67% -$14.8K ﹤0.01% 6608
2016
Q3
$24K Buy
+3,750
New +$19.1K ﹤0.01% 6054

Other funds holding PLSE

Bank of America's PLSE Position: Q1 2026 in Review

Bank of America increased its Pulse Biosciences (PLSE) stake by 8.2% in Q1 2026, buying an estimated $1.22M and bringing the position to 866,061 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Bank of America first reported a position in PLSE in Q3 2016 and has held it in 39 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Bank of America held 866,061 shares of Pulse Biosciences worth $18.7M as of Q1 2026.
  • Bank of America bought 65,884 Pulse Biosciences shares in Q1 2026, an estimated $1.22M.
  • Pulse Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2449 holding.
  • Bank of America first reported a position in Pulse Biosciences in Q3 2016 and has held it in 39 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.